The CDC Advisory Committee on Immunization Practices will convene 20-21 October 2021. ACIP typically holds three meetings each year at CDC in Atlanta, Georgia to make vaccine recommendations. Due to the coronavirus disease 2019 (COVID-19) pandemic, ACIP meetings have been held more frequently and have been virtual only (no in-person attendance). The agenda will include
The FDA anticipates receiving a request from Pfizer to amend its emergency use authorization to allow the use of its COVID-19 vaccine in children 5 through 11 years of age. In anticipation of the request, the FDA is scheduling an Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Oct. 26 to inform the
This BARDA Industry Day 2021 Virtual Event will be held 3-4 November 2021. This annual gathering of more than 1300 stakeholders from the public and private sector provides an opportunity to increase understanding of the U.S. government medical countermeasure priorities and funding goals; interact with BARDA and ASPR staff; and showcase innovations. Innovators may apply
The 2021 Annual Synthetic Biology Consortium Meeting will take place in virtual format from November 4-5, 2021. The 2021 Synthetic Biology Consortium Meeting will facilitate networking and collaboration among synthetic biology investigators. Attendees can use this meeting to collaborate with each other on current topics in synthetic biology and engage with NIH program directors. Highlighted
The FDA will hold a virtual public meeting on November 16, 2021, on enhanced drug distribution security at the package level. The purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug
The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. FDA
The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” The next webinar in the series on December 8 will
The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16, 2021, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness, response, and recovery. A more detailed agenda will be available
The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. Join federal leaders, National Biodefense Science Board members, distinguished guests, and other experts to discuss topics related to the public health supply chain and climate change. NBSB will hear from
